We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gresham Technologies Plc | LSE:GHT | London | Ordinary Share | GB0008808825 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 163.00 | 162.00 | 164.00 | 163.00 | 163.00 | 163.00 | 2,629 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Computer Programming Service | 48.72M | 2.88M | 0.0344 | 47.38 | 136.63M |
Date | Subject | Author | Discuss |
---|---|---|---|
24/2/2021 17:08 | Please do your own research as always. | qantas | |
20/2/2021 13:25 | Please do your own research as always | qantas | |
18/2/2021 12:37 | Strong decline in coronavirus across England since January, React study shows | qantas | |
18/2/2021 11:35 | Gresham Tech Did you know that global compliance spending is predicted to rise by $9.7billion over the next 5 years? Don’t miss us in @IBSIntelligence Journal (p.41) on #regulatoryreporting challenges in 2021 or our recent industry webinar here: [...] Please do your own research as always. | qantas | |
16/2/2021 11:49 | Very Well done GHT Please do your own research as always. | qantas | |
02/2/2021 21:19 | (Senior) Sales Executive | qantas | |
20/1/2021 09:07 | UBS Group AG to invest $400 million in India’s most valuable, Paytm Please do your own research as always.. | qantas | |
14/1/2021 13:36 | Please do your own research as always... | qantas | |
13/1/2021 14:12 | Page 193 We’re delighted to be named in Corporate_Vision's 2020 Corporate Excellence Awards as Leading Provider of Data Integrity & Financial Controls Software in the UK. Please do your own research always... | qantas | |
12/1/2021 13:59 | With FINRA requesting comment on enhancements to TRACE reporting for U.S. Treasury Securities by 22 Feb, the ability to adapt as the regulation changes will be mission critical for firms in 2021 Please do your own research as always. | qantas | |
07/1/2021 15:10 | The rns could be a tidying up exercise...... Seen it happen before pre T-over. | wh1spa | |
07/1/2021 12:29 | Interesting share holding announcement - Church Commissioners for England - so it would seem that GHT qualifies as an ethical investment which is a nice little plus. However, one thing does confuse me (and perhaps I have it wrong) but the date where the 3% threshold was reached seems to be way back in August - the 12th to be precise when it seems some 680,000 were traded. I was under the impression that reporting of a threshold breach had to be done pretty much immediately. So this does not explain the high volume of shares traded yesterday, circa 1.4 million, so somebody else building a stake? | gottafly | |
07/1/2021 11:28 | Jade no I had to delete it as a senior moment xx | qantas | |
07/1/2021 11:15 | QANTAS, did you forget to include your message in your last post? | jadeticl3 | |
07/1/2021 08:35 | signs Church Commissioners for England City and country of registered office London, United Kingdom Please do your own research as always. | qantas | |
06/1/2021 20:28 | Richjp I agree Flat isn't a good word to use steady or stable is good. | qantas | |
06/1/2021 18:32 | I don't think this RNS adds much to the RNS just before Christmas, however I would have bitten someone's hand off if back in March when the Covid crisis first appeared, they had said we would have as good a year as this. I find it a pity they used the word "flat" a couple of times. They might have said something like strong, steady, or stable but that is a small point. I think it encouraging that they invested in sales and marketing in the latter part of the year. That demonstrates confidence going forward. It's not just a matter of hiring more sales people you have to invest in the technical support staff to back up the sales effort and given the time lag between new sales staff and the first orders resulting from them, that can be a considerable investment. | richjp | |
06/1/2021 13:16 | UPDATE FROM RICHARD HOLWAYS FIRM Gresham closes out 2020 in good shape Jon C Davies, 07:58, 06 January 2021 Gresham Technologies, the specialist provider of transaction control and data integrity solutions to the financial services industry, has issued a trading statement reflecting a steady performance in 2020. For the year ended 31 December, Gresham expects revenue to be down by 2% to £24.6m with the total delivered by its flagship Clareti offering, flat at £15.5m. However, recurring Clareti revenue is likely to be up 11% to £12.3m with annualised Clareti revenue expected to climb by 29% to £12.3m. As a result, Gresham expects adjusted EBITDA of at least £4.4m, representing a 7% increase on 2019. In 2020, Gresham agreed to acquire Midlands based, capital markets data automation specialist, Inforalgo Information Technology (see: Gresham acquires Inforalgo) and also completed the transition to subscription licensing. All new Clareti software business is now being written on recurring terms. Overall the expected results appear encouraging, especially when viewed in the context of the pandemic. Gresham's pipeline improved during the second half and there seems to be a healthy demand for the company's intelligent automation and connectivity solutions within financial markets. | 4-10 | |
06/1/2021 11:55 | amt agree that the results are a bit mixed but of course we do have the Covid environment to consider. Some pluses and some 'not so goods) in my view. Organic Clarity ARR increased 17% (presumably that means excluding Inforalgo) which is pretty good but the Inforalgo numbers are in my view flat and rather disappointing (the 'excuse' being that Inforalgo is a strategic acquisition). Turnover is down, albeit by just 2%, and this does not give an immediate feel good factor, particularly with the statement that overall Clareti revenues were flat. The explanation being (apart from Covid) that this is the final period of transition to the subscription model, so you have to look past the headline numbers. I am also pleased to see the absence of the 'confidence' word which is generally very over used and means little, IM has instead has used the word exciting to describe 2021 - well we shall see but that can mean many things including a roller coaster (GHT shareholders would be familiair with that). The Group's sales pipeline has apparently strenthened significantly in H2 but there is a warning that this is set against a challenging micro economic climate. Forward looking ARR for 2021 is up 29% apparently (although that will include the £1.2 million regarding the Inforalgo acquisition) so circa 30% growth would be most welcome but perhaps the minimum that should be targeted since I calculate that the organic growth (excluding Inforalgo) is circa 16%. Continued investment in sales and marketing in H2 (a traditional GHT weakness that is perhaps still work in progress) is key to accerlated growth. So overall a pretty 'steady as she goes' announcement and certainly not exciting but ..... It seems that N1Singer have released an updated note and it appear that they are pretty bullish about GHT's prospects:- "We believe our forecast of just under 30% revenue growth for Clareti is over 80% underpinned. A strengthening pipeline over H220 should make our forecasts achievable/beatable. It’s rare in this market to be able to buy into a business set to grow like this for an implied EV/ARR of just over 5x our forward Clareti ARR forecasts." So onwards and definitely upwards if N1Singer are correct. | gottafly | |
06/1/2021 07:44 | I suppose against such a terrible background the trading update is very satisfactory. Looks to me like no organic growth but didn't go backwards either. Let's hope for a return to growth in 2021. I should think there is pent up demand. | amt | |
05/1/2021 23:22 | Please do your own research as always. | qantas |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions